Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
GSK Announces Dr Vishal Sikka to Join the Board as Non-executive Director
GlaxoSmithKline plc (LSE/NYSE: GSK) has today announced that Dr Vishal Sikka, founder and CEO of […]
Arpa Garay Joins Moderna as Chief Commercial Officer
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member
Accuray Incorporated (NASDAQ: ARAY) announced today that Suzanne Winter, President, will succeed Joshua Levine as the company’s Chief Executive […]
Seed Health Appoints Former Head of J&J's Janssen Human Microbiome Institute, Dirk Gevers, as Chief Scientific Officer
Seed Health, the microbiome sciences company pioneering innovations in probiotics and live biotherapeutics, today announced […]
Carisma Therapeutics Announces Appointment Of Michael Klichinsky, PharmD, PhD, As Chief Scientific Officer
Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, […]
Medtronic Names New Chief Scientific, Medical, and Regulatory Officer
Medtronic plc (NYSE:MDT) today announced that Laura Mauri, M.D., M.S.c. has been appointed Medtronic Chief Scientific, […]
Biomunex Appoints Dr. Simon Plyte, PhD, as Chief Scientific Officer
Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapies through the discovery and development of […]
Precision Medical Products, Inc. Announces Steve Ingel As New CEO
Precision Medical Products today announced the appointment of Steven Ingel to President & CEO of Precision Medical […]
Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer
Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), today announced the appointment of Dr. Humphrey Gardner as Chief […]
Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer
Australian and US MedTech start-up Nutromics (Nutromics or the Company), a global leader in DNA-based […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more